EP. 11: Looking to the Future: Emerging Therapeutic Approaches in HER2+ Breast Cancer
June 4th 2025
Panelists discuss how emerging developments in HER2-positive (HER2+) breast cancer treatment, including novel antibody-drug conjugates, bispecific antibodies, and cytotoxic-sparing regimens for hormone receptor+ (HR+)/HER2+ disease, are creating exciting new options for patients.
